Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|29|3817-3825

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.29, 2006-10, pp. : 3817-3825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Targeted Therapy, Targeted Dosing and Targeted Delivery in Oncology: Where Do We Stand?]

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1638-1638

Bentham Science Publishers

Access to resources Recommend Favorite

Statins in Heart Failure—Where Do We Stand?

By Lyons Kristopher   McVeigh Gary   Harbinson Mark  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 99-104

Springer Publishing Company

Access to resources Recommend Favorite

Intelligent use of NSAIDs - where do we stand?

By Berger R.G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 19-30

Informa Healthcare

Access to resources Recommend Favorite

Mucosal Vaccines: Where Do We Stand?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 20, 2013-10 ,pp. : 2609-2628

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors - where do we stand?

By Neumann U.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 8, 2002-08 ,pp. : 394-394

Elsevier

Access to resources Recommend Favorite